Advanced NSCLC Targeted Therapy - ROS1
Sort by:
Yale Cancer Center
Decoding ROS1 Fusion-Positive NSCLC: From Diagnosis to Targeted Therapy
FEATURING
Amin Nassar
- 20 views
- April 9, 2025
GRACE
Reading a Molecular Testing Report in Lung Cancer
FEATURING
Karen Yun
- 35 views
- April 1, 2025
- 1
GRACE
ALK, ROS1, and RET in NSCLC: Pushing the Boundaries of Targeted Therapies
FEATURING
Christine Bestvina
- 38 views
- April 1, 2025
- 1
GRACE
Targeted Therapies for NSCLC: Overview & Surgically Resected Disease
FEATURING
Angel Qin
- 17 views
- February 28, 2025
GRACE
Targeted Therapies in Non-Metastatic Lung Cancer
FEATURING
Angel Qin
- 29 views
- February 28, 2025
Oncology 2024 Year in Review
Year in Review 2024 - Transformative FDA Approvals in Precision Oncology Across Various Cancer Types
FEATURING
Vivek Subbiah
- 3,859 views
- December 17, 2024
- 10
Fox Chase Cancer Center
Progress in Targeting ALK and ROS1 in NSCLC
FEATURING
Melina Marmarelis
- 77 views
- December 16, 2024
UChicago Medicine
Biomarker Testing in aNSCLC: Current Guidelines, Gaps, and Impact on Treatment Outcomes
FEATURING
Rajat Thawani
- 190 views
- December 6, 2024
- 6
Total Health
Selected Targeted Therapies in NSCLC - Advances in Thoracic Oncology
FEATURING
Jason Porter
- 30 views
- October 29, 2024
Springer Healthcare IME
The Era of Precision Oncology
FEATURING
Jaime Schneider
- 161 views
- October 29, 2024
- 1
Springer Healthcare IME
New Frontiers in Oncology: Advanced Diagnostics and Therapeutics
FEATURING
Solange Peters
- 223 views
- October 29, 2024
- 6
Springer Healthcare IME
Evolving Landscape of Targeted Therapies
FEATURING
Lizza Hendriks
- 81 views
- October 29, 2024
COR2ED The Heart of Medical Education
Oncogene-Addicted NSCLC Highlights From WCLC & ESMO 2024
FEATURING
Herbert Loong
- 44 views
- October 28, 2024
Insights from 2024 WCLC
WCLC 2024 Insights: The Global TRUST-II Study - Efficacy & Safety of Taletrectinib in Patients With ROS1+ NSCLC
FEATURING
Geoffrey Liu
- 38 views
- October 11, 2024
Springer Healthcare IME
The Detection of NTRK Gene Fusions in NSCLC
FEATURING
Caterina Marchiò
- 47 views
- October 1, 2024
Springer Healthcare IME
Landscape of Biomarker Testing for NSCLC
FEATURING
Fernando López-Ríos
- 177 views
- October 1, 2024
- 1
Insights from 2024 WCLC
WCLC 2024 Insights: Addition of Cytotoxic Chemotherapy to Targeted Therapy in NSCLC
FEATURING
Bruna Pellini
- 163 views
- October 1, 2024
- 1
Insights from 2024 WCLC
WCLC 2024 Summary: Intensifying Suboptimal Response to Targeted Therapy for NSCLC - Rational Targeted Combinations
FEATURING
Melina Marmarelis
- 113 views
- September 23, 2024
- 1
